AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2023
Dec 12, 2023
32093_dirs_2023-12-11_2e20fcf3-42b7-4bac-b492-116b98a11059.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-12-07
Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-07 | Common Stock | P | 74852 | $9.19 | Acquired | 36759406 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 351565 | Indirect |
| Common Stock | 492069 | Indirect |
Footnotes
F1: Volume-weighted average price.
F2: Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.
F3: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 17